Navigation Links
Outcomes Pharmaceutical Health Care(r) Becomes an ASCP MTM Provider Partner
Date:11/20/2007

PHILADELPHIA, Nov. 20 /PRNewswire-USNewswire/ -- The American Society of Consultant Pharmacists (ASCP) announces that Outcomes Pharmaceutical Health Care(r) (Outcomes(r)) has become one of ASCP's Medication Therapy Management (MTM) Provider Partners. This announcement was made today at Senior Care Pharmacy '07 -- ASCP's 38th Annual Meeting and Exhibition taking place in Philadelphia.

The need for skilled clinicians to deliver MTM services has increased dramatically since the coverage of MTM services under Medicare Part D, especially for patients residing outside of nursing facilities. ASCP's MTM Provider Partners, recognizing the excellence of ASCP members, turned to the Society to help them enlist consultant and senior care pharmacists to deliver MTM services to their contracted enrollees.

Consultant and senior care pharmacists are clinicians specially trained in geriatric pharmacotherapy who review patients' medication regimens to ensure they are receiving the most appropriate, safe, and most effective medications, and that they are used appropriately. Further, consultant and senior care pharmacists identify individuals at high risk for medication-related problems, and identify and resolve health problems that are not otherwise recognized as medication-related.

"This new partnership will expand the reach of ASCP member consultant and senior care pharmacists into community-based settings, bringing much needed clinical expertise to medically complex patients wherever they reside," said ASCP Executive Director & CEO John Feather.

Since 1999, Outcomes has specialized in delivering MTM services to patients covered under employer sponsored health benefits, Medicare Part D plans, Medicaid programs, health plans, union funds, pharmacy benefits managers, disease management firms, case management companies, and various managed care organizations.

"Across the nation, more than two million patients are eligible for Outcomes MTM programs," said Patty Kumbera, Chief Operating Officer, Outcomes Pharmaceutical Health Care(r). "We are excited to partner with ASCP to expand our network. ASCP members will join thousands of Outcomes Personal Pharmacists providing face to face MTM services, including comprehensive medication reviews, cost efficacy management, drug therapy problem resolution, and patient consultations."

"ASCP's MTM Provider Partners offer our members a unique path for providing clinical services in the community setting," said ASCP's Feather. "This has been a membership desire for some time, and we are pleased to add ASCP'S MTM Provider Partners to our roster of member benefits."

The American Society of Consultant Pharmacists, the recognized expert in geriatric pharmacotherapy, is the international professional association that provides leadership, education, advocacy, and resources to advance the practice of consultant and senior care pharmacy. ASCP's 8,000 members manage and improve drug therapy and improve the quality of life of geriatric patients and other individuals residing in a variety of environments, including nursing facilities, subacute care and assisted living facilities, psychiatric hospitals, hospice programs, and in-home and community-based care. Visit ASCP's Web site at http://www.ascp.com.


'/>"/>
SOURCE American Society of Consultant Pharmacists
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. Continued Statin Use Boosts Post-Stroke Outcomes
3. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
4. QI projects may -- or may not -- improve patient safety and outcomes
5. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
6. Bypass Off-Pump Boosts Womens Outcomes
7. Mayo Clinic study indicates medication for ADHD may help student outcomes
8. Experts Compare Colon Cancer Treatment Outcomes
9. Gene Chip Data Can Boost Cancer Outcomes
10. Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes
11. Studies suggest key correlation between lung cancer subtype and treatment outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for ... 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device ... of The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... 21, 2017 , ... Innovatum will demonstrate capabilities of fully ... Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development addresses ... patient safety. , Microscan , a global technology leader in barcoding, ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: